跳至主要内容
临床试验/CTRI/2024/04/066565
CTRI/2024/04/066565尚未招募2/3 期

A Clinical Study to assess the effect of TilaKashay in the management of Artavkshay with special reference to Oligomenorrhoea and Hypomenorrhoea.

Dr Chitrangi Dattatray Wagh1 个研究点 分布在 1 个国家目标入组 38 人开始时间: 2024年5月5日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
38
试验地点
1
主要终点
To assess the effect of Tilakashay in the management of Artavkshay with special to Oligomenorrhoea and Hypomenorrhoea

研究概览

简要总结

THE PRESENT STUDY IS CLINICAL EXPERIMENTAL STUDY.

TITLE- A CLINICAL STUDY TO ASSESS THE EFFECT OF TILAKASHAY IN THE MANAGEMENT OF ARTAVKSHAY WITH SPECIAL REFERENCE TO OLIGOMENORRHOEA AND HYPOMENORRHOEA

SAMPLE SIZE- 38

STUDY CENTRE- ACADEMIC HOSPITAL

P.G SCHOLAR- DR. CHITRANGI DATTATRAY WAGH

GUIDE- DR. MANGESH LAXMAN PATIL(ASSOCIATE PROFESSOR)

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
16.00 Year(s) 至 40.00 Year(s)(—)
性别
Female

入选标准

  • 1.Patients fulfilling cardinal symptoms of Artavkshay, i.e. a) Interval between 2 menses more than 35 days b) Duration of menstrual bleeding less than 2 days c) Menstrual Pain
  • Both married and unmarried women.

排除标准

  • 1.Patient with Menorrhagia.
  • 2.Pregnant and Lactating Amenorrhoea.
  • Hb Count less than 8gm/dl 4.Congenital Anomalies of uterus or ovaries.
  • 5.Women with any malignancy, uterine fibroid, uterine polyp, endometriosis.

结局指标

主要结局

To assess the effect of Tilakashay in the management of Artavkshay with special to Oligomenorrhoea and Hypomenorrhoea

时间窗: Treatment will be given for 3 months I.e for 12 weeks

1)To evaluate the duration of intermenstrual phase.

时间窗: Treatment will be given for 3 months I.e for 12 weeks

2) To evaluate the duration of menstrual phase.

时间窗: Treatment will be given for 3 months I.e for 12 weeks

3) To evaluate the amount of menstrual bleeding.

时间窗: Treatment will be given for 3 months I.e for 12 weeks

次要结局

  • 1. To study the effect of Tilakashay on Endomentrial thickness(3 months I.e 12 weeks)

研究者

发起方
Dr Chitrangi Dattatray Wagh
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Chitrangi Dattatray Wagh

Ymt ayurvedic medical college and hospital kharghar navi mumbai

研究点 (1)

Loading locations...

相似试验